Memorial Sloan Kettering Cancer CenterNew York, NY, United States
Disclosures:
144 - Phase II Trial of Proton Re-Irradiation+/-Chemotherapy in Previously Irradiated Recurrent Head/Neck Cancer
Sunday, September 29, 20245:05 PM – 5:15 PM ET
2554 - Genotypically-Selected Pan Cancer Trial of Camonsertib with Palliative Radiation in the Treatment of Metastatic Tumors Harboring an Ataxia-Telangiectasia Mutated (ATM) Mutation
Monday, September 30, 202410:45 AM – 12:00 PM ET